26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
The Electronic Communications Code 2017 (the Code) applies across the whole of the UK and it is ther...
Read More >
Dear YouDig?, We are finishing up a contract to start a piece of a big project. The owner is pushin...
Read More >
Fir Tree Value Master Fund, L.P. v. Jarden Corp., No. 454, 2019 (Del. July 9, 2020) - Adding to its...
Read More >
US Citizenship and Immigration Services (USCIS) announced in the Federal Register on January 31, 202...
Read More >
Take a look at a construction site today and you may see drones flying overhead, robots working on b...
Read More >
At the same time as it issued its notice of proposed rulemaking expanding the definition of “person...
Read More >